Market cap
$540 Mln
Revenue (TTM)
$324 Mln
P/E Ratio
--
P/B Ratio
0.5
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 20.03 | 4.38 | 6.83 | 1.76 | -18.66 |
| EBIT | -14.14 | -37.81 | -52.52 | -9.71 | -167.27 |
| Net Profit | -20.36 | -57.26 | -66.57 | -31.16 | -169.19 |
| EPS | -31.16 | -71.50 | -70.48 | -37.89 | -169.68 |
| Book Value | -- | -- | -2.27 | -4.06 | 11.38 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-25 | Dec-24 |
| EBIT-Margin
| -33.32 | -11.91 | -28.05 | -21.68 | -18.27 |
| Net Margin
| -- | 10.46 | -26.05 | -- | -- |
| Return on equity
| -7.71 | 0.16 | -7.88 | -5.39 | -3.76 |
| Return on Capital
| -7.58 | 0.12 | -- | -5.35 | -3.72 |
| Return on Assets
| -7.09 | 0.01 | -6.94 | -4.97 | -3.48 |
| Debt to Equity (x)
| -- | -- | 0.00 | 0.01 | 0.01 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Fulgent Genetics (FLGT)
|
--
|
-5.35
|
-3.72
|
-13.66
|
11.54
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
-7.88
Lower than Peers by 15.84
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Fulgent Genetics (FLGT)
|
-7.88
|
-5.39
|
-3.76
|
-13.97
|
11.82
|
|
Peer Median
|
7.96
|
--
|
--
|
--
|
--
|
ROA
-6.94
Lower than Peers by 9.08
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Fulgent Genetics (FLGT)
|
-6.94
|
-4.97
|
-3.48
|
-12.80
|
10.76
|
|
Peer Median
|
2.14
|
--
|
--
|
--
|
--
|
EBIT Margin
-28.05
Lower than Peers by 35.10
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Fulgent Genetics (FLGT)
|
-28.05
|
-21.68
|
-18.27
|
-60.02
|
29.89
|
|
Peer Median
|
7.06
|
--
|
--
|
--
|
--
|
Net Margin
-26.05
Lower than Peers by 29.20
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Fulgent Genetics (FLGT)
|
-26.05
|
-18.75
|
-15.07
|
-58.03
|
23.17
|
|
Peer Median
|
3.16
|
--
|
--
|
--
|
--
|
Cash Profit Margin
0.00
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Fulgent Genetics (FLGT)
|
0.00
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
6.83
Lower than Peers by 3.00
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Fulgent Genetics (FLGT)
|
6.83
|
0.14
|
-0.02
|
-0.53
|
-0.38
|
|
Peer Median
|
9.83
|
--
|
--
|
--
|
--
|
EBIT Growth
-52.52
Lower than Peers by 68.73
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Fulgent Genetics (FLGT)
|
-52.52
|
-35.08
|
70.17
|
-193.82
|
77.34
|
|
Peer Median
|
16.21
|
--
|
--
|
--
|
--
|
Net Profit Growth
-66.57
Lower than Peers by 83.75
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Fulgent Genetics (FLGT)
|
-66.57
|
-41.69
|
74.55
|
-217.03
|
37.44
|
|
Peer Median
|
17.18
|
--
|
--
|
--
|
--
|
EPS Growth
-70.48
Lower than Peers by 86.57
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Fulgent Genetics (FLGT)
|
-70.48
|
-0.41
|
0.75
|
-2.22
|
0.38
|
|
Peer Median
|
16.10
|
--
|
--
|
--
|
--
|
Book Value Growth
-1.24
Lower than Peers by 6.36
Year on year growth in book value per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Fulgent Genetics (FLGT)
|
-1.24
|
--
|
--
|
--
|
--
|
|
Peer Median
|
5.12
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.00
Lower than Peers by 0.38
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Fulgent Genetics (FLGT)
|
0.00
|
0.01
|
0.01
|
0.01
|
0.03
|
|
Peer Median
|
0.38
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.00
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Fulgent Genetics (FLGT)
|
0.00
|
0.00
|
0.00
|
0.00
|
0.02
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
6.34
Higher than Peers by 4.86
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Fulgent Genetics (FLGT)
|
6.34
|
6.48
|
4.85
|
6.96
|
7.13
|
|
Peer Median
|
1.48
|
--
|
--
|
--
|
--
|
Quick Ratio
6.18
Higher than Peers by 4.79
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Fulgent Genetics (FLGT)
|
6.18
|
6.35
|
4.74
|
6.88
|
7.08
|
|
Peer Median
|
1.38
|
--
|
--
|
--
|
--
|
Interest Coverage
-381.71
Lower than Peers by 386.03
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Fulgent Genetics (FLGT)
|
-381.71
|
-932.67
|
-304.62
|
-355.73
|
182.66
|
|
Peer Median
|
4.32
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
21.77
Higher than Peers by 8.65
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Fulgent Genetics (FLGT)
|
21.77
|
28.39
|
27.17
|
19.86
|
12.13
|
|
Peer Median
|
13.12
|
--
|
--
|
--
|
--
|
Asset Turnover
0.27
Lower than Peers by 0.51
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Fulgent Genetics (FLGT)
|
0.27
|
0.27
|
0.23
|
0.22
|
0.46
|
|
Peer Median
|
0.78
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Fulgent Genetics (FLGT)
|
--
|
95.45
|
86.64
|
83.70
|
64.44
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Fulgent Genetics (FLGT)
|
--
|
18.08
|
14.72
|
9.99
|
11.94
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Fulgent Genetics (FLGT)
|
--
|
35.25
|
34.94
|
38.01
|
31.58
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Fulgent Genetics (FLGT)
|
--
|
78.28
|
66.42
|
55.68
|
44.80
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Fulgent Genetics (FLGT)
|
--
|
-13.36
|
-13.26
|
-5.13
|
6.43
|
|
Peer Median
|
33.81
|
--
|
--
|
--
|
--
|
Price / Book Value
0.55
Lower than Peers by 3.00
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Fulgent Genetics (FLGT)
|
0.55
|
0.73
|
0.50
|
0.76
|
0.73
|
|
Peer Median
|
3.54
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Fulgent Genetics (FLGT)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
2.34
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Fulgent Genetics (FLGT)
|
2.34
|
-10.48
|
-11.78
|
-3.06
|
2.00
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
540
Higher than Peers by 169
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Fulgent Genetics (FLGT)
|
540
|
--
|
--
|
--
|
--
|
|
Peer Median
|
371
|
--
|
--
|
--
|
--
|